Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis

Authors: Wright, R. Scott, Ray, Kausik K., Raal, Frederick J., Kallend, David G., Jaros, Mark, Koenig, Wolfgang, Leiter, Lawrence A., Landmesser, Ulf, Schwartz, Gregory G., Friedman, Andrew, Wijngaard, Peter L.J., Garcia Conde, Lorena, Kastelein, John J.P.

Source: Journal of the American College of Cardiology. 77(9):1182-1193

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100136650545.0x000001&indx=1&recIds=ETOCvdc_100136650545.0x000001

EFFICACY AND SAFETY OF INCLISIRAN BY BASELINE BODY MASS INDEX: A POST HOC POOLED ANALYSIS OF THE ORION-9, ORION-10 AND ORION-11 PHASE III RANDOMIZED CONTROLLED TRIALS

Authors: Leiter, Lawrence A, Kallend, David G, Koenig, Wolfgang, Landmesser, Ulf, Ray, Kausik K, Schwartz, Gregory G, Wright, R Scott, Chiang, YannTong, Orozco, Lorena Garcia Conde, Raal, Frederick J

Source: In American Journal of Preventive Cardiology March 2023 13 Supplement

High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients

Authors: Kempen, Herman J., Asztalos, Bela F., Moerland, Matthijs, Jeyarajah, Elias, Otvos, James, Kallend, David G., Bellibas, S. Eralp, Wijngaard, Peter L.J.

Source: Arteriosclerosis, thrombosis, and vascular biology. 36(4):736-742

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100032630450.0x000001&indx=1&recIds=ETOCvdc_100032630450.0x000001

THE EFFECT OF INCLISIRAN IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: A POST HOC POOLED ANALYSIS FROM THE ORION-10 AND ORION-11 RANDOMIZED CONTROLLED TRIALS

Authors: Landmesser, Ulf, Kallend, David G., Koenig, Wolfgang, Leiter, Lawrence A., Raal, Frederick J., Ray, Kausik Kumar, Wright, Scott, Chiang, YannTong, Orozco, Lorena Garcia Conde

Source: Journal of the American College of Cardiology. 79(S):1555-1555

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100158524566.0x000001&indx=1&recIds=ETOCvdc_100158524566.0x000001

Inclisiran and cardiovascular events: a patient-level analysis of phase III trials.

Authors: Ray, Kausik K, Raal, Frederick J, Kallend, David G, Jaros, Mark J, Koenig, Wolfgang, Leiter, Lawrence A, Landmesser, Ulf, Schwartz, Gregory G, Lawrence, David, Friedman, Andrew, Conde, Lorena Garcia, Wright, R Scott, investigators, ORION Phase III

Source: European Heart Journal; 1/7/2023, Vol. 44 Issue 2, p129-138, 10p

Subject Terms: CLINICAL trials, MAJOR adverse cardiovascular events, LDL cholesterol, STROKE

EFFICACY AND SAFETY OF INCLISIRAN IN PATIENTS WITH CHRONIC KIDNEY DISEASE - A POOLED ANALYSIS FROM THREE PHASE 3 CLINICAL TRIALS (ORION-9, -10 AND -11)

Authors: Landmesser, Ulf, Ray, Kausik K., Raal, Frederick, Conde, Lorena Garcia, Jaros, Mark, Koenig, Wolfgang, Leiter, Lawrence A., Schwartz, Gregory G., Kallend, David G., Wright, R. Scott

Source: Journal of the American College of Cardiology. 77(S1):1458-1458

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162074784.0x000001&indx=1&recIds=ETOCvdc_100162074784.0x000001

ESTIMATED CARDIOVASCULAR BENEFITS OF INCLISIRAN IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE

Authors: Ray, Kausik Kumar, Conde, Lorena Garcia, Gunn, Laura H., Raal, Frederick, Wright, R. Scott, Gosselin, Nathalie H., Bonnefois, Guillaume, Smith, Patrick F., Leiter, Lawrence A., Koenig, Wolfgang, Schwartz, Gregory S., Kallend, David G., Landmesser, Ulf

Source: Journal of the American College of Cardiology. 77(S1):1462-1462

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100162074568.0x000001&indx=1&recIds=ETOCvdc_100162074568.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Abstract 11033: Efficacy and Safety of Inclisiran by Baseline Glycemic Status: A Post Hoc Pooled Analysis of the ORION-10 and ORION-11 Phase III Randomized Controlled Trials

Authors: Leiter, Lawrence A, Kallend, David G, Koenig, Wolfgang, Landmesser, Ulf, Raal, Frederick J, Ray, Kausik K, Schwartz, Gregory G, chiang, yanntong, Garcia Conde Orozco, Lorena, Wright, R S

Source: Circulation (Ovid); November 2021, Vol. 144 Issue: Supplement 1 pA11033-A11033, 1p

Abstract 11143: Efficacy and Safety of Inclisiran by Baseline Body Mass Index: A Post Hoc Pooled Analysis of the ORION-9, ORION-10 and ORION-11 Phase III Randomized Controlled Trials

Authors: Leiter, Lawrence A, Kallend, David G, Koenig, Wolfgang, Landmesser, Ulf, Ray, Kausik K, Schwartz, Gregory G, Wright, R S, chiang, yanntong, Garcia Conde Orozco, Lorena, Raal, Frederick J

Source: Circulation (Ovid); November 2021, Vol. 144 Issue: Supplement 1 pA11143-A11143, 1p